SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Net Debt · Q1 FY2026 · quarter ended Mar 2026
Net debt of -$237.3M in Q1 FY2026
Q1 FY2026 net debt was -$237.3M.
Context
- Net debt amounted to 91.8% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- (94.78M) USD
- Year-over-year change
- —
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (94.78M) | — |
Net Debt vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
- Net debt amounts to 91.8% of total assets for SGP, versus a peer median of 21.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $4.75B USD | +1.3% | +31.9% | 34.3% | |
| Sep 2026 | $3.63B USD | -3.0% | -3.1% | 11.6% | |
| Mar 2026 | -$6.75M USD | +57.7% | — | 2.2% | |
| Jun 2026 | -$11.65M USD | -376.7% | -43.0% | 1.3% | |
| Mar 2026 | -$43.2M USD | +36.8% | — | 39.4% | |
| Mar 2026 | -$57.48M USD | +5.9% | — | 19.9% | |
| Mar 2026 | -CHF 62.13M CHF | -5.7% | — | 25.5% | |
| Apr 2026 | -$94.57M USD | +30.7% | — | 21.0% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | -$237.3M USD | — | — | 91.8% |
| Mar 2026 | -$587.24M USD | -114.7% | — | 80.2% | |
| Peer median (excluding SGP) | — | +1.3% | -3.1% | 21.0% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.